NCT03742791View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

June 28, 2016

Primary Completion Date

December 12, 2016

Study Completion Date

December 12, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

TS-134

5 mg to 80 mg oral solution

DRUG

Placebo

Matched Placebo oral solution

Trial Locations (1)

91206

PAREXEL - Early Phase Clinical Unit-Los Angeles, Glendale

All Listed Sponsors
lead

Taisho Pharmaceutical R&D Inc.

INDUSTRY

NCT03742791 - Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers | Biotech Hunter | Biotech Hunter